nextbiomedical

LaNua Medical

This company develops embolisation devices that block blood flow in vessels to treat tumours and internal bleeding for radiologists and surgeons.

Instylla

This company develops resorbable liquid embolic agents used by interventional radiologists to treat hypervascular tumours and peripheral vascular conditions.

Neomedical

This company provides spinal surgery instruments and implants to hospitals and surgeons.

NeuroBionics

This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.

Silk Biomaterials

This company develops silk-based implantable medical devices for tissue regeneration, including nerve conduits and vascular grafts, for clinicians and patients requiring surgical repair.

Biomedical Solutions

This company develops endovascular thrombus removal devices for healthcare providers to treat patients suffering from acute ischemic stroke.

Okami Medical

This company develops catheter-based vascular occlusion devices to obstruct blood flow in peripheral vessels for patients and interventional physicians.

LaNua

This company develops endovascular devices for embolisation procedures to help radiologists and surgeons treat tumours, internal bleeding, and vascular malformations.